Stock NMTC NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials NeuroOne Medical Technologies Corporation

Equities

NMTC

US64130M2098

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.13 USD +1.80% Intraday chart for NeuroOne Medical Technologies Corporation -1.74% -28.48%
Mar. 26 NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System CI
Feb. 13 Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 42.78 25.23 28.5 47.4 27.39 21.3
Enterprise Value (EV) 1 44.44 24.97 25.87 40.82 16.46 16.16
P/E ratio -5.54 x -3.27 x -1.53 x -4.25 x -2.7 x -1.36 x
Yield - - - - - -
Capitalization / Revenue - - 14,794,283 x 195,104,956 x 12,921,260 x 6,249,988 x
EV / Revenue - - 13,427,248 x 167,998,736 x 7,761,717 x 4,742,168 x
EV / EBITDA -9.87 x -4.32 x -5.33 x -4.03 x -1.66 x -1.37 x
EV / FCF - -6,998,792 x -5,557,357 x -8,046,829 x -3,940,457 x -1,824,026 x
FCF Yield - -0% -0% -0% -0% -0%
Price to Book -9.89 x -20.4 x 13.8 x 7.24 x 2.85 x 3.41 x
Nbr of stocks (in thousands) 3,169 4,498 7,394 12,001 16,209 23,919
Reference price 2 13.50 5.610 3.855 3.950 1.690 0.8904
Announcement Date 12/12/18 12/20/19 12/9/20 12/15/21 12/22/22 12/15/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales - - 1.927 0.243 2.12 3.408
EBITDA 1 -4.501 -5.786 -4.855 -10.14 -9.912 -11.76
EBIT 1 -4.523 -5.813 -4.902 -10.22 -10.03 -11.96
Operating Margin - - -254.46% -4,205.75% -473.14% -350.84%
Earnings before Tax (EBT) 1 -6.844 -6.781 -13.64 -9.948 -10 -11.86
Net income 1 -6.844 -6.781 -13.64 -9.948 -10 -11.86
Net margin - - -708% -4,094.6% -471.67% -348.03%
EPS 2 -2.438 -1.716 -2.519 -0.9300 -0.6250 -0.6545
Free Cash Flow - -3.568 -4.655 -5.072 -4.176 -8.859
FCF margin - - -241.61% -2,087.76% -196.98% -259.98%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/12/18 12/20/19 12/9/20 12/15/21 12/22/22 12/15/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 0.0533 0.0401 0.0366 0.032 2.011 1.57 0.4662 0.6299 0.7418 0.9776
EBITDA 1 - - - - - - - -3.453 -3.102 -3.332
EBIT 1 -2.644 -2.809 -3.06 -2.761 -1.4 -1.784 -3.496 -3.51 -3.165 -3.39
Operating Margin -4,959.89% -7,002.32% -8,364.71% -8,616.01% -69.62% -113.67% -749.91% -557.26% -426.64% -346.8%
Earnings before Tax (EBT) 1 -2.643 -2.807 -3.058 -2.76 -1.374 -1.733 -3.523 -3.469 -3.135 -3.345
Net income 1 -2.643 -2.807 -3.058 -2.76 -1.374 -1.733 -3.523 -3.469 -3.135 -3.345
Net margin -4,958.09% -6,997.71% -8,359.95% -8,610.7% -68.33% -110.38% -755.68% -550.68% -422.65% -342.14%
EPS 2 -0.2200 -0.1800 -0.1900 -0.1700 -0.0900 -0.1100 -0.2100 -0.2000 -0.1300 -0.1400
Dividend per Share - - - - - - - - - -
Announcement Date 12/15/21 2/14/22 5/12/22 8/11/22 12/22/22 2/13/23 5/12/23 8/14/23 12/14/23 2/13/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 1.66 - - - - -
Net Cash position 1 - 0.26 2.63 6.59 10.9 5.14
Leverage (Debt/EBITDA) -0.3696 x - - - - -
Free Cash Flow - -3.57 -4.65 -5.07 -4.18 -8.86
ROE (net income / shareholders' equity) - 241% -3,292% -231% -124% -150%
ROA (Net income/ Total Assets) - -967% -116% -101% -60.4% -71.4%
Assets 1 - 0.7011 11.78 9.89 16.56 16.6
Book Value Per Share 2 -1.370 -0.2800 0.2800 0.5500 0.5900 0.2600
Cash Flow per Share 2 0 0.0600 0.5500 0.5700 0.5000 0.2200
Capex - 0.06 0.12 0.07 0.28 0.38
Capex / Sales - - 6.35% 27.61% 12.98% 11.27%
Announcement Date 12/12/18 12/20/19 12/9/20 12/15/21 12/22/22 12/15/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
NEUROONE MEDICAL TECHNOLOGIES CORPORATION Stock NeuroOne Medical Technologies Corporation
-28.48% 29.3M
SARTORIUS AG Stock Sartorius AG
-12.91% 19.08B
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-46.21% 2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+18.15% 1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-3.12% 1.61B
BIOTAGE AB Stock Biotage AB
+23.78% 1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-10.69% 1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-20.89% 905M
REVENIO GROUP OYJ Stock Revenio Group Oyj
-7.14% 716M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-18.10% 682M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. NMTC Stock
  4. Financials NeuroOne Medical Technologies Corporation